Log In
BCIQ
Print this Print this
 

TAK-272

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionDirect renin inhibitor
Molecular Target Renin
Mechanism of ActionRenin inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetic nephropathy
Indication DetailsTreat early stage diabetic nephropathy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today